Tech Company Financing Transactions
Relay Therapeutics Funding Round
Relay Therapeutics, based in Cambridge, raised $57 million from D. E. Shaw Group and Third Rock Ventures.
Transaction Overview
Company Name
Announced On
9/15/2016
Transaction Type
Venture Equity
Amount
$57,000,000
Round
Series A
Investors
D. E. Shaw Group (David Shaw)
Third Rock Ventures (Alexis Borisy)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
215 1st St. 3rd Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Relay Therapeutics (Nasdaq: RLAY) is committed to discovering and developing medicines that will make a transformative difference for patients by building the first dedicated drug discovery pipeline centered on protein motion.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sanjiv Patel
Vice President
Pascal Fortin
Vice President
Patrick Walters
Vice President
James Watters
VP - Finance
Thomas Catinazzo
VP - General Counsel
Brian Adams
VP - Human Resources
Sarah O'Brien
VP - R & D
Donald Bergstrom
Browse more venture capital transactions:
Prev: 9/15/2016: AlerSense venture capital transaction
Next: 9/15/2016: Tipalti venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs